Archives
|
Entry
|
Blogger
|
Date
|
Location
|
|
Combination Drugs Are The Future for Hepatitis C
|
Steve Worland |
11/03/09 |
San Diego
|
|
UW Scientists, Backed by Gates Foundation, Enter “Put Up or Shut Up” Phase with Portable Diagnostic
|
Luke Timmerman |
11/03/09 |
Seattle
|
|
Virdante Pharma Lands $30M in A Round to Combat Inflammation
|
Ryan McBride |
10/29/09 |
Boston
|
|
Vertex Hepatitis C Drug Wipes Out Virus For Toughest-to-Treat Patients
|
Luke Timmerman |
10/28/09 |
Boston
|
|
San Diego’s Ardea Biosciences Sees Potential for Gout Drug in Combination Treatment
|
Denise Gellene |
10/19/09 |
San Diego
|
|
Omeros Accused on Eve of IPO, Seattle Genetics Trial Fails, How Much Biotechies Really Earn, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
10/08/09 |
Seattle
|
|
Seattle’s Theraclone Strikes $18M Deal to Make Flu-Fighting Antibodies with Japanese Company
|
Luke Timmerman |
10/05/09 |
Seattle
|
|
AVI Settles In, ZymoGenetics MS Drug Fails, Dendreon’s FDA Filing Set for Mid-November & More Seattle-Area Life Sciences News
|
Luke Timmerman |
10/01/09 |
Seattle
|
|
The Quest for an HIV Vaccine
|
Lawrence Corey |
09/29/09 |
Seattle
|
|
Targeted Genetics Lives On, CellCyte Charged With Fraud, Theraclone Finds HIV Weakness, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
09/10/09 |
Seattle
|
|
Daktari Diagnostics Closes $2.8M Series A Round to Combat Global HIV Crisis
|
Ryan McBride |
09/04/09 |
Boston
|
|
Finding HIV’s Weak Spot, Scientists at Seattle’s Theraclone and San Diego’s Scripps See Opening for New Vaccine
|
Luke Timmerman |
09/03/09 |
National
|
|
Targeted Genetics Dumps Lease, Amgen’s Dmab Works in Cancer Trial, Theraclone Nabs Cash, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
07/09/09 |
Seattle
|
|
Theraclone Gets Funding for HIV
|
Luke Timmerman |
07/06/09 |
Seattle
|
|
Cell Therapeutics Ships App to FDA, Targeted Genetics Cuts Again, Sanofi CEO Looks to Biotech & More Seattle Area Life Sciences News
|
Luke Timmerman |
06/25/09 |
Seattle
|
|
Amnis Rolls Out Souped Up Scientific Tool, Just as Customers Start Feeling Flush
|
Luke Timmerman |
06/24/09 |
Seattle
|
|
Global Health Funding Booms, But Not Just From Gates, UW-Harvard Study Finds
|
Luke Timmerman |
06/18/09 |
Seattle
|
|
HIV’s “Tireless Warrior,” Anthony Fauci, Calls for Transformation of TB Research
|
Luke Timmerman |
06/18/09 |
Seattle
|
|
Concert Pharma Jamming with Glaxo in Deal with $1B-Plus Potential
|
Ryan McBride |
06/02/09 |
Boston
|
|
Targeted Genetics, Mainstay of Gene Therapy, Faces Likely Shutdown
|
Luke Timmerman |
05/07/09 |
Seattle
|
|
NewPath Picks Up $30M, Asemblon Raises $2.9M, Amazon Buys Lexcycle, & More Seattle-Area Deals News
|
Gregory T. Huang |
04/28/09 |
Seattle
|
|
PATH Gets $52M for HIV Work
|
Luke Timmerman |
04/24/09 |
Seattle
|
|
Anadys Hepatitis C Drug Shows Potent Effect in Small Study
|
Luke Timmerman |
04/23/09 |
San Diego
|
|
Amylin Braces to Battle Carl Icahn, Calit2’s Network for Institutional Innovation, Sangart Ponders Its Next Move, & More San Diego BizTech News
|
Bruce V. Bigelow |
04/13/09 |
San Diego
|
|
Dendreon Saga Nears Climax, Gregoire Biotech Fund in Jeopardy, UW’s Biofuel Futurist, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
04/09/09 |
Seattle
|
|
Ardea Biosciences, in Moment of Serendipity, Discovers HIV Drug That May Work for Gout
|
Luke Timmerman |
04/08/09 |
San Diego
|
|
Antibodies for HIV, Long Dismissed, Show Signs of Comeback at Seattle’s Theraclone
|
Luke Timmerman |
04/07/09 |
Seattle
|
|
UW’s Protein Guru, David Baker, Eyes Alternative Biofuels, Vaccines in New 3-D Structures
|
Luke Timmerman |
04/02/09 |
Seattle
|
|
Genzyme Enters Seattle Hub, Oncothyreon Bets on Cancer Drugs, Pathway Nabs $40M, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
04/02/09 |
Seattle
|
|
Genzyme Gene Therapy Fails To Help People with Leg Disease Walk Longer
|
Luke Timmerman |
03/31/09 |
Boston
|
|
Page 1 of
3 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.
© 2007-2009, Xconomy, Inc.
XCONOMY is a registered service mark of Xconomy, Inc.
All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
